Search research articles
Contact Us
Filters
Showing results (1361-1370 of 1,385) with videos related to
Page
of 139
Sort By:
International Journal of Cancer
|
December 22, 2015
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
S Rachel Skinner, Cosette M Wheeler, Barbara Romanowski, et al.
Preventive Medicine Reports
|
February 5, 2025
Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping
Alisa P Young, Mutiya Olorunfemi, Leigh Morrison, et al.
Frontiers in Neurology
|
March 21, 2019
Incidence, Recurrence, and Risk Factors for Peri-ictal Central Apnea and Sudden Unexpected Death in Epilepsy
Laura Vilella, Nuria Lacuey, Johnson P Hampson, et al.
The Journal of Hospital Infection
|
September 8, 2019
Reducing Implant Infection in Orthopaedics (RIIiO): Results of a pilot study comparing the influence of forced air and resistive fabric warming technologies on postoperative infections following orthopaedic implant surgery
M Kümin, J Deery, S Turney, et al.
Journal of Medicinal Chemistry
|
June 22, 2017
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT<sub>2C</sub> Receptor Agonists
Joseph Carpenter, Ying Wang, Gang Wu, et al.
International Journal of Cancer
|
August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
A Szarewski, W A J Poppe, S R Skinner, et al.
The Lancet. Oncology
|
November 15, 2011
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Cosette M Wheeler, Xavier Castellsagué, Suzanne M Garland, et al.
Gynecologic Oncology
|
September 4, 2012
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial
Edith Roset Bahmanyar, Jorma Paavonen, Paulo Naud, et al.
Frontiers in Neurology
|
March 1, 2021
Seizure Clusters, Seizure Severity Markers, and SUDEP Risk
Manuela Ochoa-Urrea, Nuria Lacuey, Laura Vilella, et al.
Journal of the American Heart Association
|
February 8, 2023
Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network
Jeanne M Clark, W Timothy Garvey, Kevin D Niswender, et al.
Page
of 139
Search research articles
Search
Showing results (1361-1370 of 1,385) with videos related to
Sort By:
Page
of 139
International Journal of Cancer
|
December 22, 2015
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
S Rachel Skinner, Cosette M Wheeler, Barbara Romanowski, et al.
Preventive Medicine Reports
|
February 5, 2025
Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping
Alisa P Young, Mutiya Olorunfemi, Leigh Morrison, et al.
Frontiers in Neurology
|
March 21, 2019
Incidence, Recurrence, and Risk Factors for Peri-ictal Central Apnea and Sudden Unexpected Death in Epilepsy
Laura Vilella, Nuria Lacuey, Johnson P Hampson, et al.
The Journal of Hospital Infection
|
September 8, 2019
Reducing Implant Infection in Orthopaedics (RIIiO): Results of a pilot study comparing the influence of forced air and resistive fabric warming technologies on postoperative infections following orthopaedic implant surgery
M Kümin, J Deery, S Turney, et al.
Journal of Medicinal Chemistry
|
June 22, 2017
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT<sub>2C</sub> Receptor Agonists
Joseph Carpenter, Ying Wang, Gang Wu, et al.
International Journal of Cancer
|
August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
A Szarewski, W A J Poppe, S R Skinner, et al.
The Lancet. Oncology
|
November 15, 2011
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Cosette M Wheeler, Xavier Castellsagué, Suzanne M Garland, et al.
Gynecologic Oncology
|
September 4, 2012
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial
Edith Roset Bahmanyar, Jorma Paavonen, Paulo Naud, et al.
Frontiers in Neurology
|
March 1, 2021
Seizure Clusters, Seizure Severity Markers, and SUDEP Risk
Manuela Ochoa-Urrea, Nuria Lacuey, Laura Vilella, et al.
Journal of the American Heart Association
|
February 8, 2023
Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network
Jeanne M Clark, W Timothy Garvey, Kevin D Niswender, et al.
Page
of 139